Isolated limb perfusion in the management of locally advanced extremity soft tissue sarcoma.
In conclusion, ILP is an interesting and important treatment option in the management of locally advanced extremity soft tissue sarcomas. Large medical centers, dealing with referrals and an important caseload of STS patients, should develop this treatment option and have it readily available to offer patients the best chances for limb salvage. In Europe, the success of TNF-based ILP has lead to the training, accreditation, and activation of TNF-based ILP programs in over 30 cancer centers since the approval of TNF for this indication in 1999. Thus, country by country centers for referral programs are established to deal with those categories of patients that can greatly benefit from the availability and integration of this treatment option in the STS treatment programs.
Eggermont
Alexander M
AM
Department of Surgical Oncology, Erasmus University Medical Center-Daniel Den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA, Rotterdam, The Netherlands. eggermont.@chih.azr.nl
D000970:Antineoplastic Agents / Q000008:administration & dosage; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D002986:Clinical Trials as Topic; D005121:Extremities / Q000473:pathology; D006801:Humans; D009361:Neoplasm Invasiveness; D012509:Sarcoma / Q000188:drug therapy / Q000473:pathology*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy / Q000473:pathology*
D000970:Antineoplastic Agents